1
|
de Jager SC and Kuiper J: Vaccination
strategies in atherosclerosis. Thromb Haemost. 106:796–803. 2011.
View Article : Google Scholar : PubMed/NCBI
|
2
|
Sabers CJ, Martin MM, Brunn GJ, Williams
JM, Dumont FJ, Wiederrecht G and Abraham RT: Isolation of a protein
target of the FKBP12-rapamycin complex in mammalian cells. J Biol
Chem. 270:815–822. 1994. View Article : Google Scholar
|
3
|
Cheng-Lai A and Frishman WH:
Sirolimus-eluting coronary stents: novel devices for the management
of coronary artery disease. Am J Ther. 11:218–228. 2004. View Article : Google Scholar : PubMed/NCBI
|
4
|
Klugherz BD, Llanos G, Lieuallen W, et al:
Stent-based delivery of sirolimus for the prevention of resrenosis.
J Am Coll Cardiol. 35(Suppl 1): 58A2000.
|
5
|
Gallo R, Padurean A, et al: Inhibition of
intimal thickening after balloon angioplasty in porcine coronary
arteries by targeting regulators of the cell cycle. Circulation.
99:2164–2170. 1999. View Article : Google Scholar : PubMed/NCBI
|
6
|
Zhang JA, Anyarambhatla G, Ma L, Ugwu S,
Xuan T, Sardone T and Ahmad I: Development and characterization of
a novel Cremophor EL free liposome-based paclitaxel (LEP-ETU)
formulation. Eur J Pharm Biopharm. 59:177–187. 2005. View Article : Google Scholar
|
7
|
Li C and Deng Y: A novel method for the
preparation of liposomes: freeze drying of monophase solutions. J
Pharm Sci. 93:1403–1414. 2004. View Article : Google Scholar : PubMed/NCBI
|
8
|
Lu YP, Lasne C and Chouroulinkov I: Use of
an orthogonal design method to study two-stage chemical
carcinogenesis in BALB/3T3 cells. Carcinogenesis. 7:893–898. 1986.
View Article : Google Scholar : PubMed/NCBI
|
9
|
Levy MY and Benita S: Drug release from
submicronized O/W emulsion: a new in vitro kinetic evaluation
model. Int J Pharm. 66:291990. View Article : Google Scholar
|
10
|
Rouf MA, Bilensoy E, Vural I and Hıncal
AA: Determination of stability of sirolimus following exposure to
different conditions. Eur J Pharm Sci. 32(Suppl): S462007.
|
11
|
Higuchi WI, Tzeng CS, Chang SJ, Chiang HJ
and Liu CL: Estimation of cholesterol solubilization by a mixed
micelle binding model in aqueous
tauroursodeoxycholate:lecithin:cholesterol solutions. J Pharm Sci.
97:340–349. 2008. View Article : Google Scholar
|
12
|
Ravi PR, Ganga S and Saha RN: Design and
in vitro evaluation of zidovudine oral controlled release tablets
prepared using hydroxypropyl methylcellulose. Chem Pharm Bull
(Tokyo). 56:518–524. 2008. View Article : Google Scholar
|
13
|
Lionberger RA, Raw AS, Kim SH, Zhang X and
Yu LX: Use of partial AUC to demonstrate bioequivalence of Zolpidem
Tartrate Extended Release formulations. Pharm Res. 29:1110–1120.
2012. View Article : Google Scholar : PubMed/NCBI
|
14
|
Masaka T, Matsuda T, Li Y, et al:
Synthesis of VIP-lipopeptide using a new linker to modify
liposomes: Towards the development of a drug delivery system for
active targeting. Chem Pharm Bull (Tokyo). 61:1184–1187. 2013.
View Article : Google Scholar
|
15
|
Wang X, Lin Y, Zeng Y, Sun X, Gong T and
Zhang Z: Effects of mycophenolic acid-glucosamine conjugates on the
base of kidney targeted drug delivery. Int J Pharm. 456:223–234.
2013. View Article : Google Scholar : PubMed/NCBI
|
16
|
Pehlivan SB: Nanotechnology-based drug
delivery systems for targeting, imaging and diagnosis of
neurodegenerative diseases. Pharm Res. 30:2499–2511. 2013.
View Article : Google Scholar : PubMed/NCBI
|
17
|
Arias JL: Liposomes in drug delivery: a
patent review (2007 - present). Expert Opin Ther Pat. 23:1399–1414.
2013. View Article : Google Scholar : PubMed/NCBI
|
18
|
Murakami M, Cabral H, Matsumoto Y, et al:
Improving drug potency and efficacy by nanocarrier-mediated
subcellular targeting. Sci Transl Med. 3:64ra22011. View Article : Google Scholar : PubMed/NCBI
|
19
|
Musacchio T and Torchilin VP: Recent
developments in lipid-based pharmaceutical nanocarriers. Front
Biosci (Landmark Ed). 16:1388–1412. 2011. View Article : Google Scholar
|
20
|
Roger M, Clavreul A, Venier-Julienne MC,
Passirani C, Montero-Menei C and Menei P: The potential of
combinations of drug-loaded nanoparticle systems and adult stem
cells for glioma therapy. Biomaterials. 32:2106–2116. 2011.
View Article : Google Scholar
|
21
|
Suo X, Deng Y and Hao A: Determination of
lauroyl-indapamide in rat whole blood by high-performance liquid
chromatography. J Chromatogr B Analyt Technol Biomed Life Sci.
819:191–196. 2005. View Article : Google Scholar : PubMed/NCBI
|
22
|
Torchilin VP, Narula J, Halpern E and Khaw
BA: Poly(ethylene glycol)-coated anti-cardiac myosin
immunoliposomes: factors influencing targeted accumulation in the
infarcted myocardlium. Biochem Biophys Acta. 1279:75–83. 1996.
View Article : Google Scholar
|
23
|
Chen Y, Deng YJ and Hao YL: Surface
modification of liposomes for cardiomyocytes targeting in vitro.
Pharmazie. 60:238–240. 2005.PubMed/NCBI
|
24
|
Chen Y, Deng YJ, Hao YL, Hao AJ, Zhong HJ
and Wang XM: Uptake of liposomes by cultured cardiomyocytes.
Pharmazie. 60:844–848. 2005.PubMed/NCBI
|
25
|
Nag OK and Awasthi V: Surface engineering
of liposomes for stealth behavior. Pharmaceutics. 25:542–569. 2013.
View Article : Google Scholar
|
26
|
Paszko E and Senge MO: Immunoliposomes.
Curr Med Chem. 19:5239–5277. 2012. View Article : Google Scholar : PubMed/NCBI
|
27
|
Shen J and Burgess DJ: In vitro
dissolution testing strategies for nanoparticulate drug delivery
systems: recent developments and challenges. Drug Deliv Transl Res.
3:409–415. 2013. View Article : Google Scholar : PubMed/NCBI
|